OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of antidepressant and antipsychotic use on weight gain: A systematic review
Lucia Alonso‐Pedrero, Maira Bes‐Rastrollo, Amelia Martí
Obesity Reviews (2019) Vol. 20, Iss. 12, pp. 1680-1690
Closed Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Handbook of Religion and Health
Harold G. Koenig, Tyler J. VanderWeele, John R. Peteet
Oxford University Press eBooks (2023)
Closed Access | Times Cited: 1065

Antidepressant Medications and Weight Change: A Narrative Review
Hartej Gill, Barjot Gill, Sabine El‐Halabi, et al.
Obesity (2020) Vol. 28, Iss. 11, pp. 2064-2072
Open Access | Times Cited: 129

Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Xiying Fu, Yicun Wang, Fangyi Zhao, et al.
Aging (2023)
Open Access | Times Cited: 32

Medication-Induced Weight Change Across Common Antidepressant Treatments
Joshua Petimar, Jessica G. Young, Yu Han, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 8, pp. 993-1003
Closed Access | Times Cited: 9

Food inequity and insecurity and MASLD: burden, challenges, and interventions
Shira Zelber‐Sagi, Patrizia Carrieri, Juan M. Pericàs, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 10, pp. 668-686
Closed Access | Times Cited: 9

Eating Disorders: An Evolutionary Psychoneuroimmunological Approach
Markus J. Rantala, Severi Luoto, Tatjana Krama, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 62

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
Sue Shea, Christos Lionis, Chris Kite, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1697-1697
Open Access | Times Cited: 53

Post-traumatic stress disorder, dyssomnias, and metabolic syndrome
Victoria Serhiyenko, V.B. Sehin, V.І. Pankiv, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 1, pp. 58-67
Open Access | Times Cited: 8

Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
Liliana Dell’Osso, Chiara Bonelli, Benedetta Nardi, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 7

Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis
Benjamin I. Perry, Emanuele F. Osimo, Rachel Upthegrove, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 7, pp. 589-598
Open Access | Times Cited: 34

Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update
Ann Verhaegen, Luc F. Van Gaal
Current Obesity Reports (2021) Vol. 10, Iss. 1, pp. 1-13
Closed Access | Times Cited: 32

Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis
Hiba Mutwalli, Johanna Louise Keeler, Sevgi Bektas, et al.
Journal of Psychiatric Research (2023) Vol. 160, pp. 137-162
Open Access | Times Cited: 11

Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access

Association of antidepressant use with obesity risk in pregnant women: a retrospective cohort study
Carolyn Breadon, Shalini Arunogiri, Alisa Turbic, et al.
Journal of Psychosomatic Obstetrics & Gynecology (2025) Vol. 46, Iss. 1
Open Access

Risque et maladies cardiovasculaires dans les troubles psychiatriques sévères
O. Godin
Archives des Maladies du Coeur et des Vaisseaux - Pratique (2025)
Open Access

The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice
Moriah L. Jacobson, Hildegard A. Wulf, Caroline A. Browne, et al.
Psychopharmacology (2020) Vol. 237, Iss. 12, pp. 3715-3728
Open Access | Times Cited: 30

The Rise and Fall of Dopamine: A Two-Stage Model of the Development and Entrenchment of Anorexia Nervosa
Jeff A. Beeler, Nesha S. Burghardt
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 17

Disrupting the Mood and Obesity Cycle: The Potential Role of Metformin
Stacey N. Doan, Sunita K. Patel, Bin Xie, et al.
Obesities (2023) Vol. 3, Iss. 1, pp. 59-75
Open Access | Times Cited: 10

Metabolic disorders induced by psychotropic drugs
André Scheen
Annales d Endocrinologie (2023) Vol. 84, Iss. 3, pp. 357-363
Closed Access | Times Cited: 10

Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
豊田 隆謙, Xiaoyan He, Y. Liu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 10

The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial
L. Riley Gournay, Morgan L. Ferretti, Sarah A. Bilsky, et al.
Psychopharmacology (2023) Vol. 240, Iss. 10, pp. 2147-2161
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top